Skip to main content
. 2021 Mar 6;13(5):1131. doi: 10.3390/cancers13051131

Figure 4.

Figure 4

Figure 4

Age subgroup disproportionality analysis of safety reports associated with either immune checkpoint inhibitors or other antineoplastic drugs in older patients (aged ≥65 years). Suspected adverse drug reactions were clustered according to the Medical Dictionary for Regulatory Activities (MedDRA) System Organ Classes, version 23.0. Vertical bars on the ROR estimates indicate the 95% confidence intervals. Abbreviations: ICI, immune checkpoint inhibitor; ROR, reporting odds ratio.